Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Medpace Holdings Inc (F: 01P)

 
01P Technical Analysis
5
As on 11th Dec 2025 01P SHARE Price closed @ 480.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 347.07 & Strong Buy for SHORT-TERM with Stoploss of 328.82 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

01PSHARE Price

Open 474.80 Change Price %
High 481.20 1 Day 1.50 0.31
Low 472.10 1 Week -21.40 -4.27
Close 480.00 1 Month -22.80 -4.53
Volume 5 1 Year 160.60 50.28
52 Week High 536.20 | 52 Week Low 245.70
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
NT5 1000000.00 4629529.50%
NT5 1000000.00 4629529.50%
NT5 1000000.00 4629529.50%
30T 1000000.00 3759298.50%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
LDB 1.71 -92.57%
 
 
01P
Daily Charts		 01P
Intraday Charts		 Whats New @
Bazaartrend		 01P
Free Analysis
 
01P Important Levels Intraday
RESISTANCE497.54
RESISTANCE491.91
RESISTANCE488.44
RESISTANCE484.96
SUPPORT475.04
SUPPORT471.56
SUPPORT468.09
SUPPORT462.46
 
01P Forecast December 2025
Share
4th UP Forecast534.34
3rd UP Forecast516.91
2nd UP Forecast506.14
1st UP Forecast495.37
1st DOWN Forecast464.63
2nd DOWN Forecast453.86
3rd DOWN Forecast443.09
4th DOWN Forecast425.66
 
01P Weekly Forecast
4th UP Forecast508.91
3rd UP Forecast499.64
2nd UP Forecast493.91
1st UP Forecast488.18
1st DOWN Forecast471.83
2nd DOWN Forecast466.10
3rd DOWN Forecast460.37
4th DOWN Forecast451.10
 
01P Forecast2025
4th UP Forecast1116.87
3rd UP Forecast912.62
2nd UP Forecast786.37
1st UP Forecast660.12
1st DOWN Forecast299.88
2nd DOWN Forecast173.63
3rd DOWN Forecast47.38
4th DOWN Forecast-156.87
 
 
01P Other Details
Segment EQ
Market Capital 6504995328.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
 
01P Address
01P
 
01P Latest News
 
Your Comments and Response on Medpace Holdings Inc
 
01P Business Profile
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio. Address: 5375 Medpace Way, Cincinnati, OH, United States, 45227
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service